The category of PAL [65]. by Juntong Lai (21464598)

“…The minimum damage leading to persistent inflammation is decreased as BMI increases and the correlation is nonlinear, which suggests a significant rise in OA risk with a high level of obesity. …”

The description of dimensional parameters. by Juntong Lai (21464598)

“…The minimum damage leading to persistent inflammation is decreased as BMI increases and the correlation is nonlinear, which suggests a significant rise in OA risk with a high level of obesity. …”

The formula of parameter nondimensionalisation. by Juntong Lai (21464598)

“…The minimum damage leading to persistent inflammation is decreased as BMI increases and the correlation is nonlinear, which suggests a significant rise in OA risk with a high level of obesity. …”

S1 Data - by Yumeng Zhang (3115050)

“…The results of this study suggest that the level of well-being as a whole, as well as in the eastern, central and western regions increased significantly over the period, with an “east-to-west decreasing” distribution in China. …”

Index system for well-being level. by Yumeng Zhang (3115050)

“…The results of this study suggest that the level of well-being as a whole, as well as in the eastern, central and western regions increased significantly over the period, with an “east-to-west decreasing” distribution in China. …”

PRISMA flowchart of the included studies. by Gaelle Salame (21077899)

“…While some studies failed to show desired results, the overall effect was an increase in C-peptide levels and a decrease in HbA1c levels. However, the study did not achieve statistical significance for insulin dosing. …”

Characteristics of Included Studies. by Gaelle Salame (21077899)

“…While some studies failed to show desired results, the overall effect was an increase in C-peptide levels and a decrease in HbA1c levels. However, the study did not achieve statistical significance for insulin dosing. …”

(A-H). Case 1: primary subcutaneous facial alveolar echinococcosis. by Louis Bohard (22250661)

Vinpocetine improves survival rate in DENA-exposed rats. by Osama A. Mohammed (18548092)

PTEN KD increases chromatin accessibility. by Ahmed H. Ghobashi (12705573)

PTEN KD induces EMT in epithelial CRC cells. by Ahmed H. Ghobashi (12705573)

Functional predictions and abundance top 15. by Xia Deng (613144)

“…The FUN Guild prediction showed that six groups of plant pathogens and plant saprotrophs changed significantly (<i>P <</i> 0.05), the amount of harmful bacteria in the soil increased while the amount of arbuscular mycorrhizal fungui (AMF) decreased, leading to a continuous cropping obstacle of lavender. …”

Effects of βHB treatment on edema and NDS 3 days after ICH. by Noam H. Sander (13977976)

“…<p>A) In experiment 2, body weight was decreased on day 1 after ICH (p<0.0001), but not different between treatment groups at all times assessed (all p≥0.2118). …”

Initial assessment of βHB treatment effects. by Noam H. Sander (13977976)

“…This increase was significantly reduced in the βHB group (p = 0.0210). …”

Caffeine induces proteome-wide changes in a Rob-dependent manner. by Christoph Binsfeld (21763112)

Comparative metabolome analysis of case (fearful dogs) versus controls. by Luigi Sacchettino (12288497)

Localization and expression of cell-to-cell connection proteins in bma-miRNA transfected and NC hLECs. by Hailey Johnson (18217167)

“…<b>(H)</b> No significant changes to ITGA5 relative protein expression were observed (n = 3). …”

Included studies basic characteristics. by Xuqin Du (8803772)

“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO₂ (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO₂ (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”

Forest plot for FVC. by Xuqin Du (8803772)

“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO₂ (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO₂ (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”

All data extracted. by Xuqin Du (8803772)

“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO₂ (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO₂ (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”